Apatinib
CH-H&N-008-1
Phase 2 small_molecule active
Quick answer
Apatinib for Head and Neck Neoplasms is a Phase 2 program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chinese University of Hong Kong
- Indication
- Head and Neck Neoplasms
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active